Kidney Cancer Trial, Recruiting NCT06916624 Sponsor: The Affiliated Hospital of Qingdao University Condition: Kidney Cancer
Back to Kidney Cancer

Kidney Cancer Trial, Recruiting

NCT06916624
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are able to understand and voluntarily sign a consent form, and are willing and able to follow the trial procedures
  • People aged between 18 and 75 years (any gender)
  • People who have been diagnosed with, or are suspected to have, kidney cancer (renal cell carcinoma), or who have had kidney cancer treatment and have a suspected return or spread of the cancer
  • People who have at least one measurable solid tumour that can be tracked over time using standard imaging measurement methods
  • People whose general physical condition is rated as reasonably functional on a standard medical scale (ECOG score of 0–2, meaning able to carry out at least some daily activities)
  • People whose blood test results meet specific minimum levels for white blood cells, platelets, haemoglobin, and clotting, and whose liver and kidney function blood results fall within acceptable ranges as defined by the trial
  • People with an expected survival of at least 12 weeks
  • People who are able and willing to use effective contraception during the trial and for 6 months afterwards (this applies to both male and female participants)

Who may not be able to join:

  • People who are recovering from a major injury or surgery that occurred within the 4 weeks before the trial assessment
  • People who have a serious active infection (throughout the body or in a specific area) or other significant serious health conditions
  • People with severely reduced liver or kidney function
  • People who decline to take part in the study
  • People who have a known allergy to any ingredient in the imaging agent used in the trial, or who have a history of significant allergies
  • People of childbearing potential (male or female) who are unable or unwilling to use effective contraception
  • Women who are planning a pregnancy, are currently pregnant, or are breastfeeding
  • People who are unable or unwilling to have a PET/CT scan
  • People whom the trial investigators determine to be unsuitable for other reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-0532-82913318

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Affiliated Hospital of Qingdao University
Registry
ClinicalTrials.gov
Start date
12 April 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

SUV

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov